De Burlo Group Inc Neurocrine Biosciences Inc Transaction History

De Burlo Group Inc

$734 Million
Q2 2024

A detailed history of De Burlo Group Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, De Burlo Group Inc holds 5,117 shares of NBIX stock, worth $583,338. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,117

Previous 5,167 0.97%

Holding current value

$583,338

Previous $712,000 1.12%

% of portfolio

0.1%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $6,543 - $7,159	-50 Reduced 0.97%	5,117 $704,000
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $521,600 - $574,960	-4,000 Reduced 43.63%	5,167 $712,000
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $843,639 - $988,294	9,167 New	9,167 $973,000
Q2 2022 Aug 11, 2022	SELL	$75.79 - $100.07 $707,348 - $933,953	-9,333 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $105,052 - $137,474	-1,450 Reduced 13.45%	9,333 $874,000
Q4 2021 Jan 28, 2022	SELL	$79.65 - $106.22 $55,755 - $74,354	-700 Reduced 6.1%	10,783 $918,000
Q1 2021 May 06, 2021	SELL	$87.57 - $119.4 $8,757 - $11,940	-100 Reduced 0.86%	11,483 $1.12 Million
Q4 2020 Feb 05, 2021	SELL	$86.91 - $108.33 $26,073 - $32,499	-300 Reduced 2.52%	11,583 $1.11 Million
Q3 2020 Nov 05, 2020	BUY	$96.16 - $135.15 $12,789 - $17,974	133 Added 1.13%	11,883 $1.14 Million
Q1 2020 May 07, 2020	SELL	$75.11 - $113.76 $22,533 - $34,128	-300 Reduced 2.49%	11,750 $1.02 Million
Q4 2019 Feb 06, 2020	SELL	$86.8 - $118.57 $26,040 - $35,571	-300 Reduced 2.43%	12,050 $1.3 Million
Q2 2019 Aug 07, 2019	SELL	$72.24 - $91.27 $21,672 - $27,381	-300 Reduced 2.37%	12,350 $1.04 Million
Q1 2019 May 09, 2019	SELL	$69.31 - $91.53 $252,981 - $334,084	-3,650 Reduced 22.39%	12,650 $1.11 Million
Q4 2018 Feb 07, 2019	SELL	$68.32 - $124.36 $40,991 - $74,616	-600 Reduced 3.55%	16,300 $1.16 Million
Q4 2017 Feb 08, 2018	SELL	$58.53 - $77.59 $46,824 - $62,072	-800 Reduced 4.52%	16,900 $1.31 Million
Q3 2017 Nov 02, 2017	BUY	$47.97 - $61.28 $849,069 - $1.08 Million	17,700	17,700 $1.08 Million

Others Institutions Holding NBIX

# of Institutions

640

Shares Held

95.2M

Call Options Held

661K

Put Options Held

227K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Neurocrine Biosciences Inc Transaction History